BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Costa CFFA, Sampaio-Maia B, Araujo R, Nascimento DS, Ferreira-Gomes J, Pestana M, Azevedo MJ, Alencastre IS. Gut Microbiome and Organ Fibrosis. Nutrients 2022;14:352. [PMID: 35057530 DOI: 10.3390/nu14020352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Chen J, Li L, Zhang H, Pang D, Ouyang H, Jin X, Tang X. Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice. Microbiol Spectr 2022;10:e0252422. [PMID: 36318049 DOI: 10.1128/spectrum.02524-22] [Reference Citation Analysis]
2 Hua X, Xu L, Li Q, Zhang M, Chen X, Zhu Y, Xu J, Li J. Deep Grouping Analysis of the Altered Cervical Canal Microbiota in Intrauterine Adhesion Patients. Reprod Sci 2022;29:3494-507. [PMID: 35710962 DOI: 10.1007/s43032-022-01006-w] [Reference Citation Analysis]
3 Wang M, Lu S, Zhao H, Liu Z, Sheng K, Fang J. Natural polysaccharides as potential anti-fibrotic agents: A review of their progress. Life Sci 2022;308:120953. [PMID: 36103957 DOI: 10.1016/j.lfs.2022.120953] [Reference Citation Analysis]
4 Wrigley-carr HE, van Dorst JM, Ooi CY. Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes. Medicine in Microecology 2022;13:100057. [DOI: 10.1016/j.medmic.2022.100057] [Reference Citation Analysis]
5 Drapkina OM, Yafarova AA, Kaburova AN, Kiselev AR. Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives. Biomedicines 2022;10:2019. [DOI: 10.3390/biomedicines10082019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shi L, Du X, Zuo B, Hu J, Cao W. Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-11. [DOI: 10.1155/2022/2894659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhao Y. Recent advances of gut microbiota in chronic kidney disease patients. Exploration of Medicine. [DOI: 10.37349/emed.2022.00090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Muriel P. Role of gut dysbiosis in chronic liver disease leading to fibrosis. Hepatic Fibrosis 2022. [DOI: 10.1016/b978-0-323-99764-5.00006-8] [Reference Citation Analysis]